Skip to main content

Your search for “RNA Therapeutics” returned 116 results

Researchers Discover New Genetic Brain Disorder in Humans

April 24, 2014

A newly identified genetic disorder associated with degeneration of the central and peripheral nervous systems in humans, along with the genetic cause, is reported in the April 24, 2014 issue of Cell.

New Cancer Immunotherapy Approach Turns Immune Cells into Tiny Anti-Tumor Drug Factories

December 4, 2018

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs.

A Potential New Target for Head and Neck Cancer Immunotherapy

March 13, 2023

UC San Diego researchers have identified a strong association between the product of a gene expressed in most cancers and elevated levels of white blood cells that produce antibodies within tumors, suggesting a new therapeutic target.

Engineering Graduate Students Honored as Siebel Scholars

September 23, 2020

Five Jacobs School of Engineering graduate students conducting pioneering biomedical research have been named Siebel Scholars.

Schmidt Futures Fellows Seek to Expand Promise of AI in STEM Fields

March 23, 2023

Ten UC San Diego postdoctoral scholars are applying artificial intelligence (AI) methods to their research in a range of fields thanks to support from the Eric and Wendy Schmidt AI in Science Postdoctoral Fellowship, a program of Schmidt Futures.

Stem Cell ‘Collaboratory’ Opens on UC San Diego Campus

December 6, 2011

…advancing and fulfilling the therapeutic promise of stem cells. The consortium opened its doors with a ribbon-cutting ceremony involving dozens of local officials, scientists, and patient advocates. But more than just a celebration of the opening of a building, the event exalted the driving idea behind it: Stem cell researchers…

Scientists Try Old Weapon Against Deadly New Target

October 23, 2014

…improved ways to deliver therapeutic drugs inside cells, agreed to help. Funding from NIAID arrived within days. Over the next few years, he and colleagues created multiple analogs or variations of cidofovir. The first was brincidofovir. In cultured cell tests, the compound proved active against an array of viruses, blocking…

UC San Diego Awarded $8 Million to Uncover Genetic Foundations of Substance Use Disorders

October 28, 2024

UC San Diego has received a five-year, $8 Million grant to support a NIDA P30 Center to investigate the genetics, genomics, and epigenetics behind substance use disorders.

Organoids Derived From Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s Disease

September 26, 2024

UC San Diego researchers discover two distinct molecular subtypes of Crohn’s disease using patient-derived organoids, opening the door to personalized treatment for the chronic inflammatory bowel disease.

Engineering Undergraduates Use DNA Origami to Target Cancer

February 16, 2017

…origami in fields like therapeutics and bioelectronics. We’re applying it to targeted drug delivery,” said Raina Borum, a fourth year nanoengineering major and the team lead for the project. The team chose to design a “sleeve”—think Christmas stocking—to carry the hidden cargo. But the shape isn’t what makes the design…

Category navigation with Social links